tiprankstipranks
Trending News
More News >

Argenica Therapeutics Lists New Securities on ASX

Story Highlights
Argenica Therapeutics Lists New Securities on ASX

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Argenica Therapeutics Ltd ( (AU:AGN) ).

Argenica Therapeutics Ltd announced the quotation of 352,345 ordinary fully paid securities on the ASX, following advice to list these shares, which were previously subject to voluntary escrow. This move potentially enhances the company’s market presence and liquidity, offering stakeholders increased opportunities for investment and engagement.

The most recent analyst rating on (AU:AGN) stock is a Buy with a A$1.14 price target. To see the full list of analyst forecasts on Argenica Therapeutics Ltd stock, see the AU:AGN Stock Forecast page.

More about Argenica Therapeutics Ltd

Argenica Therapeutics Ltd operates in the biotechnology industry, focusing on developing therapeutic solutions. The company is engaged in advancing treatments for neurological conditions, aiming to improve patient outcomes in this specialized market.

Average Trading Volume: 94,515

Technical Sentiment Signal: Buy

See more insights into AGN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1